Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: if the true value of the settlement - Roseny1
4
Mar 10, 2008 04:41AM
3
Mar 10, 2008 04:47AM

Mar 10, 2008 06:00AM

Mar 10, 2008 06:04AM

Mar 10, 2008 06:15AM

Mar 10, 2008 06:31AM

Mar 10, 2008 07:06AM
2
Mar 10, 2008 09:31AM

I would think that if customary royalty payments (based on future sales of infringing product) were to be forthcoming, the disclosure would be simply that and nothing more - "ongoing royalty payments will be forthcoming based on future sales of infringing product by certain entites/a certain entity".

Saying more would not only likely violate the CC, but would also not be in PTSC/TPL's best interest, as it would reveal details (e.g., royalty amount per infringing unit sold) that could adversely affect future negotiations.

JMHO,

SGE

Share
New Message
Please login to post a reply